产品详情
Targets
Target | Value | |
---|---|---|
EphB4 | ED50 | 25nM |
C-Raf | IC50: 0.395μM | |
c-Src | IC50: 1.266μM | |
c-Abl | IC50: 1.667μM | |
Tie-2 | IC50: >10μM | |
Axl | IC50: >10μM | |
HER1 | IC50: >10μM | |
PKA | IC50: >10μM | |
CDK1 | IC50: >10μM | |
PKB | IC50: >10μM | |
PDK-1 | IC50: >10μM | |
FGFR3 | IC50: >10μM | |
c-Met | IC50: >10μM |
In vitro (25°C) | DMSO | 90 mg/mL (178.75 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL (5.95 mM) | ||
In vivo | NMP+PEG300 (10+90, v+v) | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.86 mL | 99.3 mL | 198.61 mL |
0.5 mM | 3.97 mL | 19.86 mL | 39.72 mL |
1 mM | 1.99 mL | 9.93 mL | 19.86 mL |
5 mM | 0.4 mL | 1.99 mL | 3.97 mL |
*The above data is based on the productmolecular weight 503.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10661 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 503.5 |
Formula | C26H20F3N7O |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 940310-85-0 |
Synonyms | NVPBHG712 |
SMILES | CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=NC(=NC4=C3C=NN4C)C5=CN=CC=C5 |
产品标签
Product Questions
Product Questions
PLX4032 (Vemurafenib)
PLX4032(Vemurafenib)也称为RG7204,Vemurafenib,R7204,RO5185426。PLX4032是B-raf抑制剂,IC50为44 nM。
Dabrafenib (GSK2118436A)
Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂,具有V600E突变,目前正在临床试验中。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…
Dabigatran ethyl ester
Dabigatran ethyl ester是一种新兴的口服抗凝剂,是凝血酶活性的直接抑制剂。